Author | Luis Paz-Ares, MD, PhD | OncLive

Author | Luis Paz-Ares, MD, PhD

Articles

Dr. Paz-Ares on Connection of EGFR-Expression and Necitumumab Response in NSCLC

April 15, 2016

Video

Luis Paz-Ares, MD, PhD, Professor of Medicine at Hospital Universitario 12 de Octubre in Madrid, Spain, discusses a subgroup analysis of patients with EGFR-expressing tumors from the SQUIRE trial, a phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone as first-line treatment for patients with stage IV squamous non-small cell lung cancer (NSCLC).

Dr. Paz-Ares Discusses the Use of Pemetrexed for NSCLC

June 17, 2011

Video

Dr. Paz-Ares From Seville University Hospital Discusses the Use of Pemetrexed for NSCLC

Dr. Paz-Ares Discusses Pemetrexed Clinical Trial

June 13, 2011

Video

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

x